Page last updated: 2024-10-19

phenylpyruvic acid and Cardiovascular Diseases

phenylpyruvic acid has been researched along with Cardiovascular Diseases in 1 studies

phenylpyruvic acid: RN given refers to parent cpd
phenylpyruvate : A 2-oxo monocarboxylic acid anion resulting from deprotonation of the carboxy group of either keto- or enol-phenylpyruvic acid.
keto-phenylpyruvic acid : A 2-oxo monocarboxylic acid that is 3-phenylpropanoic acid substituted by an oxo group at position 2. It is an intermediate metabolite in the phenylalanine pathway.

Cardiovascular Diseases: Pathological conditions involving the CARDIOVASCULAR SYSTEM including the HEART; the BLOOD VESSELS; or the PERICARDIUM.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Zhu, Y1
Dwidar, M1
Nemet, I1
Buffa, JA1
Sangwan, N1
Li, XS1
Anderson, JT1
Romano, KA1
Fu, X1
Funabashi, M1
Wang, Z1
Keranahalli, P1
Battle, S1
Tittle, AN1
Hajjar, AM1
Gogonea, V1
Fischbach, MA1
DiDonato, JA1
Hazen, SL1

Other Studies

1 other study available for phenylpyruvic acid and Cardiovascular Diseases

ArticleYear
Two distinct gut microbial pathways contribute to meta-organismal production of phenylacetylglutamine with links to cardiovascular disease.
    Cell host & microbe, 2023, 01-11, Volume: 31, Issue:1

    Topics: Animals; Cardiovascular Diseases; Gastrointestinal Microbiome; Glutamine; Mice

2023